Global Hesperidin Market Strategic Research Report

Scope of the Report

The global Hesperidin market size is predicted to grow from US$ 133 million in 2025 to US$ 212 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.

Hesperidin (also known as orange peel glycoside) is a natural flavonoid glycoside compound derived primarily from citrus peels, *Fructus Aurantii Immaturus* (immature bitter orange fruit), sweet orange peel, and bitter orange peel. Commercial products typically appear as pale yellow to off-white powders and are generally produced through a series of processes—including extraction, concentration, precipitation, crystallization, purification, drying, and pulverization—using citrus by-products or Fructus Aurantii Immaturus as raw materials. It is primarily used in dietary supplements, functional foods, pharmaceutical intermediates, as a raw material for diosmin, as an active ingredient in cosmetics, and for scientific research and testing. In 2025, global sales volume reached approximately 7,600 metric tons, with an average unit price of about $17,900 per ton and a global capacity utilization rate of approximately 67.5%. Upstream industry players include citrus growers and processors, suppliers of *Fructus Aurantii Immaturus* raw materials, traders of plant extract raw materials, providers of extraction solvents (ethanol and water), manufacturers of filtration and separation equipment, drying and pulverization equipment, and packaging materials, as well as third-party testing agencies. Downstream enterprises include manufacturers of dietary supplements, functional foods, pharmaceutical raw materials, diosmin, and cosmetic ingredients, as well as companies specializing in plant extract blending, scientific research reagents, and nutritional health brands; the industry's average gross profit margin is approximately 36.5%. Regarding the cost structure, raw materials such as citrus peel and *Fructus Aurantii Immaturus* account for approximately 31%; extraction solvents and auxiliary materials account for about 12%; energy and water treatment account for about 8%; extraction, concentration, and crystallization processes account for about 13%; and drying, pulverization, and screening account for about 7%. Labor and factory management account for approximately 8% of costs; testing, quality control, and registration documentation for 6%; packaging, warehousing, and logistics for 7%; environmental treatment for 5%; and other expenses for 3%. The demand list encompasses raw materials for dietary supplements, upstream raw materials for diosmin, citrus bioflavonoids, antioxidant ingredients for functional foods, botanical active ingredients for cosmetics, pharmaceutical intermediates, high-purity reference standards, traceable raw materials with low pesticide residues, and micronized products. The list of downstream clients includes health supplement brands, nutritional ingredient distributors, pharmaceutical raw material manufacturers, diosmin producers, functional food factories, beverage and powder formulation companies, cosmetic ingredient suppliers, botanical extract compounders, scientific reagent companies, and export clients. Business opportunities are driven by policies supporting natural plant extract exports, the resource utilization of citrus by-products, upgraded quality regulations for food and pharmaceuticals, compliance management for cosmetic ingredients, and incentives for the development of Traditional Chinese Medicine (TCM) and natural products. Technological innovation drivers include high-efficiency extraction and purification, control of residual solvents, high-purity HPLC testing, micronization processing, enzymatic conversion, continuous crystallization, and traceable raw material management. Shifts in consumer demand are reflected in a move away from generic plant extracts toward high-quality flavonoid raw materials characterized by clearly defined natural origins, stable purity, low pesticide and heavy metal levels, complete documentation, batch-to-batch consistency, and suitability for healthy aging needs.

Hesperidin is a specialized product within the categories of mature plant extracts and natural flavonoid raw materials. With global sales volume reaching approximately 7,600 tons in 2025, the market is characterized by steady demand rather than explosive growth. This stability is underpinned by the sectors for natural health ingredients, the high-value utilization of citrus by-products, venous health products, antioxidant additives, functional foods, and the diosmin supply chain. On the supply side, China remains the primary global production and export hub; enterprises in regions such as Sichuan, Hunan, Shaanxi, and Henan handle the bulk of commodity-scale supply, leveraging access to *Aurantii Fructus Immaturus* (immature bitter orange) and citrus raw materials, expertise in extraction and purification, supporting pharmaceutical intermediate infrastructure, and cost advantages. In contrast, companies in Europe, the US, and Japan tend to focus on reagent-grade products, small-package formats, high-purity reference standards, and end-consumer brand channels. Over the next two to five years, standard food-grade hesperidin will continue to face price competition—particularly as low-purity citrus flavonoids and trading-oriented products drive price disparities—while demand will rise for products that are pharmaceutical-grade, high-purity, traceable, and meet strict standards for low solvent residues, pesticide residues, and heavy metals, as well as micronized specifications. Downstream customers are increasingly demanding robust quality systems, reliable delivery, and comprehensive export documentation; this shift will drive the industry away from low-price competition for bulk commodities toward competition based on quality differentiation. Enterprises capable of controlling raw materials, performing extraction and purification, conducting HPLC testing, managing environmental compliance, passing customer audits, and leveraging synergies within the diosmin supply chain will be better positioned to secure stable orders and achieve higher gross margins. Overall, while the hesperidin market is growing at a moderate pace, the product mix will continue to evolve, with high-end applications and the pharmaceutical supply chain serving as the primary drivers for improved profitability.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hesperidin market?

What factors are driving Hesperidin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hesperidin market opportunities vary by end market size?

How does Hesperidin break out by Purity, by Application?

This report presents a comprehensive overview of the global Hesperidin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Purity

• 90%-92% Type
• 93%-98% Type
• Others

Segment by Physical Form

• Amorphous Powder
• Crystalline Form
• Other

Segment by Water Solubility

• Natural Hesperidin
• Water-soluble Hesperidin Derivative

Segment by Application

• Pharmaceutical intermediates
• Food
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hesperidin market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceutical intermediates, Food, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact